Program Lead, SER-301 and SER-155 @ (February 2019 - February 2022)
Director, Microbiome Sciences @ (November 2018 - January 2020)
Group Leader, Microbiome Sciences @ (August 2017 - November 2018)
Program Lead, SER-155 @ (January 2017 - August 2020)
Senior Scientist, Microbiome Sciences @ (September 2015 - August 2017)
Postdoctoral Fellow @ (November 2013 - September 2015)
Post Doctoral Researcher, Regev Lab @ (January 2013 - November 2013)
Postdoctoral Fellow (Visiting Scientist) @ (September 2012 - January 2013)
Graduate Research Fellow @ (August 2007 - September 2012)
Coordinator @ Boston TB Group (January 2009 - January 2011)
Head Resident @ Residence Life- College of W&M (August 2006 - May 2007)
Resident Assistant @ Residence Life- College of W&M (August 2005 - August 2006)
Certified Pharmacy Technician @ (September 2003 - April 2007)
Medical Assistant and Grant Coordinator @ Norge Primary Care- Angels of Mercy (September 2002 - July 2003)
Christopher Ford Education
Harvard T.H. Chan School of Public Health
PhD (Infectious Disease and Immunology)
2007-2012
William & Mary
MA (Biology)
2006-2007
William & Mary
BS (Biology)
2002-2006
Christopher Ford Skills
Infectious Diseases
Immunology
Public Health
Research
Cell Culture
Cell Biology
Molecular Biology
PCR
Matlab
Mathematical Modeling
Lifesciences
Cell
Protein Chemistry
Flow Cytometry
Life Sciences
Science
PowerPoint
Teaching
Christopher Ford Summary
Christopher Ford, based in Cambridge, MA, US, is currently a Global Program Lead, Tuberculosis Therapeutics at Gates Medical Research Institute. Christopher Ford brings experience from previous roles at Seres Therapeutics. Christopher Ford holds a 2007 - 2012 PhD in Infectious Disease and Immunology @ Harvard T.H. Chan School of Public Health. With a robust skill set that includes Infectious Diseases, Immunology, Public Health, Research, Cell Culture and more. Christopher Ford has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Christopher Ford?
Find contact details for 700 million professionals.